PubMed · 2020 · 10 citations · 32 references
Open access
MedicineOrthopaedic SurgeryOrthopedic SurgeryInflammationRegenerative MedicineStem Cell BiologyCartilage DegenerationCartilage MetabolismCartilage RegenerationMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyOsteoarthritisChondrogenic DifferentiationInflammatory Mediators In CartilageMatrix Degradation
BACKGROUND: Osteoarthritis (OA) is a chronic disease that attacks joints and bones which can be caused by trauma or other joint diseases. Stem cell and Conditioned Medium (CM) of stem cells are developed for OA therapy, which is minimally invasive. It can decrease inflammation and be a replacement for knee surgery. This study aimed to utilize human Wharton's Jelly-Mesenchymal Stem Cells (hWJMSCs) as an alternative OA therapy. METHODS: expression) were determined. RESULTS: chondrogenic markers was found in IL1β-CHON002 treatment using 15% CM of hWJMSCs induced with IGF1. CM of hWJMSCs can reduce inflammatory cytokines (TNFα and IL10) and matrix degradation mediator MMP3. Better result was gained from IGF1-induced hWJMSCs-CM. CONCLUSION: CM of IGF1-hWJMSCs reduce inflammation while repairing injured joint in the human chondrocyte OA model.
32
Matrix Elasticity Directs Stem Cell Lineage Specification
Adam J. Engler, Shamik Sen, H. Lee Sweeney et al. · Cell · 2006 · 13.7K citations · Full text
Paola Romina Amable, Marcus Vinicius Telles Teixeira, Rosana Bizon Vieira Carias et al. · Stem Cell Research & Therapy · 2014 · 354 citations · Full text